Creegan & Nassoura Financial Group, LLC Novartis Ag Transaction History
Creegan & Nassoura Financial Group, LLC
- $147 Million
- Q1 2025
A detailed history of Creegan & Nassoura Financial Group, LLC transactions in Novartis Ag stock. As of the latest transaction made, Creegan & Nassoura Financial Group, LLC holds 11,325 shares of NVS stock, worth $1.27 Million. This represents 0.86% of its overall portfolio holdings.
Number of Shares
11,325
Previous 11,400
0.66%
Holding current value
$1.27 Million
Previous $1.11 Million
13.8%
% of portfolio
0.86%
Previous 0.75%
Shares
13 transactions
Others Institutions Holding NVS
# of Institutions
1,524Shares Held
142MCall Options Held
1.63MPut Options Held
1.82M-
Dodge & Cox San Francisco, CA11.8MShares$1.32 Billion0.81% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.16 Billion0.98% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.61MShares$963 Million0.25% of portfolio
-
Morgan Stanley New York, NY7.06MShares$789 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa6.76MShares$757 Million0.33% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $241B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...